Ricardo Benavente is an Extraordinary Professor and Academic Director in the Department of Cell and Developmental Biology at the University of Würzburg's Biocenter. He leads the Benavente Lab, focusing on meiotic processes and synaptonemal complex (SC) structure. His career includes a Dr. med. from the University of Heidelberg, a habilitation (Dr. rer. nat. habil.), and postdoctoral work as an Alexander von Humboldt Fellow at the German Cancer Research Center. Research interests center on the functional organization of the cell nucleus during meiosis, particularly the synaptonemal complex and telomere dynamics. Techniques used include super-resolution microscopy and electron tomography, applied to mouse models and comparative studies across metazoans. Key findings include insights into SC protein conservation and meiotic chromosome behavior. Publications highlight structural studies of SC components (e.g., SYCP proteins), telomere-nuclear envelope interactions, and evolutionary aspects of meiosis. He contributed to the Latin-American Academy of Sciences since 2001 and collaborates with institutions like Uruguay's Clemente Estable Institute. His work bridges molecular mechanisms of meiosis with evolutionary biology, emphasizing structural and functional insights into genetic variability.
Stephen Dewhurst, Ph.D., is Vice President for Research and Chief Research Officer at the University of Rochester (UR) and Vice Dean for Research at the UR School of Medicine and Dentistry (SMD). He holds a professorship in the Department of Microbiology and Immunology (SMD). His administrative roles include former department chair (2009–2021), SMD Senior Associate Dean for Basic Research (2007–2009), and codirector of UR’s Center for AIDS Research (2008–2020). Dr. Dewhurst’s research focuses on virology, with 30+ years’ experience including HIV neuropathogenesis, vaccine development, and innate immune responses. He leads NIH-funded programs in graduate education and Deaf postdoctoral training. His mentorship has guided 29 Ph.D. students, 16 postdoctoral fellows, and >100 undergraduates, earning awards like the William H. Riker Award (2008) for graduate education. Key scientific contributions include HIV humanized mouse models, antiviral therapeutics, and MLK inhibitors for neuroinflammation. His patents span viral vectors, integrin-binding monobodies, and influenza vaccines. Awards include membership on NIH study sections (e.g., HIV Immunopathogenesis) and editorial roles in virology journals.
Emilyn U Alejandro is an Associate Professor in the Department of Physiology at the University of Minnesota, affiliated with the Healthy Weight Research Center and Lillehei Heart Institute. Her research explores molecular mechanisms linking nutrient sensing to metabolic health across developmental and chronic disease contexts. Research Interests: Focus on post-translational modifications (e.g., O-GlcNAc Transferase) regulating pancreatic beta-cell function, mTOR nutrient-sensing pathways, placental development in intrauterine growth restriction, and circadian disruption's impact on glucose homeostasis. Article Trends: Recent work examines diabetes type 2 progression through autophagy regulation, placental insulin signaling's role in offspring metabolism, and stress sensor proteins in fetal growth restriction. Key methodologies include mouse models, molecular profiling, and systems biology approaches. Students: Mentors graduate student Her, T. K. on metabolic health projects. Grants: Leads NIH-funded initiatives on diabetes research, placental nutrient transport, and systems biology training programs. Labs/Teams: Collaborates with Lillehei Heart Institute researchers and contributes to the Healthy Weight Research Center's interdisciplinary efforts.
Lance A. Johnson, PhD, is an Associate Professor in the Department of Physiology at the University of Kentucky College of Medicine. He is also affiliated with the Sanders-Brown Center on Aging and the Nutritional Sciences Graduate Faculty. His research focuses on the role of Apolipoprotein E (APOE) in cerebral metabolism and neurodegeneration, particularly in Alzheimer’s disease. Department: Department of Physiology School: College of Medicine Institution: University of Kentucky Lab: Johnson Lab, Healthy Kentucky Research Building Dr. Johnson’s research investigates how APOE isoforms, especially APOE4, influence brain metabolism through glial contributions. His lab uses transcriptomic and metabolomic techniques across models—from cells to mice to humans—to identify early metabolic dysregulations. Key projects include studying the pentose phosphate pathway, lipid droplet dynamics, and developing the novel APOE 'switch mouse' model to test therapeutic replacement of APOE4 with neuroprotective APOE2. His recent publications span neuroscience, oncology, metabolism, and clinical research. Notably, he co-authored a 2024 Science perspective on APOE and IDO1 in Alzheimer’s, and contributed to studies in Nature on cancer metastasis and Nature Nanotechnology on gene-editing nanoparticles. These reflect a broad interdisciplinary impact, though his core focus remains on brain aging and metabolic resilience. Scientific contributions include: Development of the APOE 'switch mouse' model Creation of the APOE Immunometabolism Database Leadership in multi-lab collaborations (e.g., with Morganti and Sun labs) Dr. Johnson mentors a diverse team of PhD candidates, MD/PhD students, and research analysts. He serves as Director of Graduate Studies in Physiology, indicating active academic leadership. He has not received any explicitly mentioned awards in the provided text. His lab recently relocated to expanded space in the Healthy Kentucky Research Building, supporting ongoing growth. No part-time status or retirement indications are present.
Eugenia Trushina, Ph.D., is a Professor of Neurology and Pharmacology at Mayo Clinic in Rochester, Minnesota, where she serves as a Consultant in the Department of Neurology and the Department of Molecular Pharmacology and Experimental Therapeutics. Her research is centered on mitochondrial dysfunction in neurodegenerative diseases such as Alzheimer's and Huntington's disease, aging, and chemotherapy-induced neuropathy. Ph.D. in Chemistry, Saratov State University Postdoctoral Fellowship, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Dr. Trushina’s research focuses on the molecular mechanisms of mitochondrial dynamics and function in neurons, particularly how environmental toxins, genetic factors, and chemotherapy drugs contribute to neurodegeneration. Her lab is developing biomarkers for early detection of mitochondrial dysfunction and testing mitochondria-targeted therapeutics to reverse neurodegeneration. Recent work emphasizes mitochondrial complex I inhibition, metabolomics in inclusion body myositis, and neuroprotective small molecules in Alzheimer’s models. Her publication and grant activity show a strong trend in targeting mitochondrial pathways—such as mitophagy, oxidative stress, and metabolic dysregulation—for therapeutic intervention in neurodegenerative and age-related disorders. This includes both preclinical models and translational biomarker development. Dr. Trushina’s research has been funded by: National Institute on Aging (NIA) National Institute of Neurological Disorders and Stroke (NINDS) Mayo Clinic Alzheimer's Disease Research Center Alzheimer Drug Discovery Foundation American Health Assistance Foundation She has served as Principal Investigator (PI) and Co-PI on multiple NIH grants, including ongoing projects on mitochondrial complex I as a neuroprotective target and the role of chronic alcohol exposure in Alzheimer’s pathophysiology. She mentors junior researchers and collaborates across disciplines, though specific student names are not listed. Her work is conducted within the Mitochondrial Neurobiology and Therapeutics research group at Mayo Clinic.
Alexander Margaret is an Assistant Professor in the Department of Medical Microbiology and Immunology at the University of Wisconsin–Madison, School of Medicine and Public Health. She leads an independent research laboratory focused on understanding how diet, gut microbiota, and immune responses interact to influence autoimmune diseases. Her lab employs advanced techniques including gnotobiotic mouse models, anaerobic microbiology, sequencing, and metabolic assays to uncover mechanistic insights into host-microbe interactions. Dr. Alexander earned her PhD in Biology from the University of Utah, where she studied immune cell communication under Dr. Ryan O’Connell. She completed her postdoctoral training at the University of California, San Francisco, with Dr. Peter Turnbaugh, investigating how autoimmune-related microbiota members modulate immune responses. She launched her independent research program at UW–Madison in January 2024. Her research focuses on two major themes: (1) microbiota-dependent mechanisms by which diets modulate immune responses in autoimmunity, and (2) targeting dietary interventions by understanding how disease-associated microbes influence immunity. These efforts are supported by grants from the NIH NIAID (R00), the Shaw Early Career Research Award (Greater Milwaukee Foundation), and internal funding from the University of Wisconsin–Madison (OVCRGE, SMPH, MMI). The articles published by Dr. Alexander and her collaborators reveal a strong trend in immunometabolism and microbiome-immune crosstalk. Her work consistently explores how host and microbial metabolites—shaped by diet or drugs—regulate immune cell function, particularly Th17 cells, in inflammatory and autoimmune contexts. The research spans basic microbial physiology to translational applications in precision medicine. NIH NIAID R00 Shaw Early Career Research Award (Greater Milwaukee Foundation) Dr. Alexander mentors a dynamic team of graduate students, postdoctoral scholars, and undergraduate researchers. Lab members include Wenxuan Dong (Biophysics PhD), Gillian Hughes (MDTP PhD), Bethany Korwin-Mihavics (Postdoc), and Chi (Felix) Yan (Postdoc). She emphasizes structured mentorship through weekly 1:1 meetings, annual Individual Development Plan (IDP) discussions, and a collaborative lab culture that values creativity, curiosity, and open communication. While she does not currently have grants listing named trainees, her lab is actively involved in training the next generation of scientists in interdisciplinary approaches to immunology and microbiome research. The Alexander Lab is based in the Microbial Sciences Building at UW–Madison and fosters a vibrant, collaborative environment. The lab team investigates complex systems using diverse methodologies and encourages interdisciplinary collaboration. Though newly established, the lab has already initiated traditions such as lab picnics, art days, and social gatherings to build camaraderie. The lab culture emphasizes celebrating well-designed experiments regardless of outcome, learning from mistakes, and maintaining a supportive atmosphere for scientific growth.
Han Li is a permanent researcher and structural leader at the Institut Pasteur in Paris, affiliated with the team Membrane, Cytosquelette et Division Cellulaire under the Department of Cell Biology and Infection. Han Li leads research projects focused on cellular plasticity in aging and cancer, exploring mechanisms of cellular reprogramming, senescence, and regeneration. Research Interests: Cellular reprogramming and stem cell biology Mechanisms of aging and cellular senescence Aberrant plasticity in cancer development In vivo models of tissue regeneration Gene regulation in pluripotency (e.g., Sox2) The recent publications highlight work in in vivo reprogramming, particularly in skeletal muscle, using mouse models to study how injury-induced senescence can be leveraged for regenerative purposes. The research bridges fundamental cell biology with implications for regenerative medicine and oncology. Scientific Contributions: Pioneering studies on injury-induced senescence enabling reprogramming Development of assays for detecting senescence during reprogramming Exploration of p27 and Sox2 in dysplastic cell states Han Li supervises PhD students and postdoctoral researchers, contributing to training the next generation of scientists in cell and developmental biology. The work is supported by institutional funding and collaborative initiatives at Institut Pasteur, including LabEx Revive in regenerative biology. Laboratory and Team: The research is conducted within a dynamic team studying cell division, cytoskeleton, and cellular identity, with access to advanced core facilities including organ-on-chip and animal models.
Wei Chao, MD, PhD , is a Professor at the University of Maryland School of Medicine with primary appointments in Anesthesiology and secondary appointments in Physiology . He serves as Vice Chair for Translational Research and Co-Director of the STAR Center . MD from Hunan Medical College, China PhD in Biochemistry, University of Texas Postdoc at University of California, San Diego Dr. Chao's research spans sepsis , trauma , and ischemic myocardial injury , focusing on innate immunity , microRNA , and bioinformatics . His work integrates mouse genetics , physiology , and machine learning to identify biomarkers and therapeutic targets. Recent publications highlight his team's discoveries in extracellular RNA sensing, TLR7 signaling , and coagulopathy in critical illnesses. His 15 most recent articles address topics like sepsis-induced organ injury, miRNA-based diagnostics, and inflammation mechanisms. Dr. Chao has received prestigious awards including the R35 Maximizing Investigators’ Research Award (NIGMS, 2021), Frontiers in Anesthesia Research Award (IARS, 2018-2021), and Colin Mackenzie & Cristina Imle Mentoring Prize (2021). He has been continuously funded by NIH for over 20 years, DoD since 2017, and holds grants from the Air Force and National Science Foundation .
Fabian Gaessler is an Assistant Professor at the Universitat Pompeu Fabra (Department of Economics and Business) and an Affiliated Research Fellow at the Max Planck Institute for Innovation and Competition since 2022. He also serves as an Affiliated Professor at the Barcelona School of Economics and previously held academic roles at IESE Business School (2019) and Technical University of Munich (2018–2019). Education: Doctoral Studies (2013–2015) at Max Planck Institute for Innovation and Competition Postgraduate Law and Economics (2010–2013) at International Max Planck Research School M.Sc. in Organization, Management and Governance (2009–2010) at London School of Economics Honors Degree in Technology Management (2008–2011) at Center for Digital Technology and Management, Munich B.Sc. in Business Administration (2005–2009) at LMU Munich and University of California, Santa Barbara Research Interests focus on innovation economics , patent policy , and AI applications in strategic decision-making . His work bridges empirical industrial organization and technology management , with key contributions on patent enforcement, data exclusivity, and human-AI collaboration in innovation. Key Article Trends include: Patent oppositions and follow-on innovation AI as a training tool in strategic environments Market exclusivity impacts on pharmaceutical R&D Physical capital shocks in scientific productivity Bifurcated patent litigation systems Scientific quality and patent value linkages Scientific Awards : 2017: Otto Hahn Medal of the Max Planck Society Advising and Grants : While direct student advisement is not explicitly listed, Gaessler has collaborated extensively with scholars like Dietmar Harhoff, Karin Hoisl, and Henning Piezunka. His research has been supported by institutions including the Max Planck Society, European Commission, and ZEW. Labs and Teams : Affiliated with the Innovation and Entrepreneurship Research group at Max Planck Institute for Innovation and Competition. His work involves cross-institutional collaborations with European patent litigation experts and biomedical research teams.
Milan K. Bagchi is the Deborah Paul Professor of Molecular & Cellular Biology and Director of the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. He also holds a joint appointment as Professor of Molecular & Integrative Physiology. His research focuses on steroid hormone signaling mechanisms in reproduction and disease, particularly estrogen and progesterone regulation of embryo implantation and cancer biology. Education: B.S. (1976), M.S. (1979) from University of Calcutta, India; Ph.D. (1984) from University of Nebraska; Postdoc (1985–89) at Baylor College of Medicine. Research interests include endocrinology, reproductive biology, and signal transduction. Key areas: hormonal regulation of implantation, gene networks in fertility, and molecular basis of hormone-dependent cancers. His lab uses mouse models and genomic approaches to study uterine function and hormonal pathways. Notable awards: Romano Professorial Scholar and University Scholar. Recent work highlights include studies on phthalate impacts on uterine physiology (2023), hypoxia-driven embryo implantation mechanisms (2025), and decidualization pathways. His publications span hormone signaling, environmental toxin effects, and cell communication in reproductive systems. Awards and honors include roles as a distinguished scholar and contributions to biomedical research. Collaborations extend to institutions like the Carle Illinois College of Medicine and the Carl R. Woese Institute of Genomic Biology.
Dr. Shana Stoddard is an Associate Professor of Chemistry at Rhodes College, where she leads the Molecular Immunotherapeutics Research (MIR) lab. Her research program focuses on improving patient outcomes with autoimmune disorders, cancer, neurological disorders, and coronaviruses through protein engineering, computational chemistry, and rational drug design. Dr. Stoddard received her educational training from: Postdoctoral Researcher at St. Jude Children's Research Hospital (Diagnostic Imaging) Ph.D. in Chemistry and Biochemistry from University of Mississippi M.Ed. in Curriculum and Instruction (emphasis Special Education) from Freed-Hardeman University B.S. in Chemistry from Prairie View A&M University Dr. Stoddard's research interests span multiple areas of biomedical science with a focus on therapeutic development. Her work in autoimmune disorders centers on primary membranous nephritis (PMN), where she develops auto-antibody-specific inhibitors and antigen-specific therapies. In cancer research , she focuses on designing selective histone deacetylase (HDAC) inhibitors for various cancer types, particularly targeting HDAC8 for neuroblastoma treatment. Her lab also works on neurological disorders , developing HDAC4 inhibitors for Huntington's disease and glioblastoma. During the COVID-19 pandemic, her lab pivoted to coronavirus antiviral development , creating peptide-based fusion inhibitors and protease inhibitors. Additionally, Dr. Stoddard is deeply committed to diversity and equity in STEM education , developing pedagogical approaches to create more inclusive classrooms. Analysis of Dr. Stoddard's recent publications reveals a consistent focus on structure-based drug design across multiple therapeutic areas. Her work employs computational chemistry approaches to model protein structures and design inhibitors with improved selectivity. A significant portion of her research targets histone deacetylases (HDACs), with emphasis on achieving isozyme selectivity among the 18 different HDAC enzymes. Her lab has made contributions to understanding protein structures involved in autoimmune kidney diseases and developed computational models of previously uncharacterized proteins. Dr. Stoddard has received numerous prestigious awards recognizing both her research and mentorship: 2025 – LMI Mellon Fellow 2024 – Lloyd N Ferguson Young Scientist Award from NOBCChE 2024 – Sigma Xi, The Scientific Research Honor Society inductee 2024 – Ruth Kirschstein Diversity in Science Award from ASBMB 2023 – Tyrone Mitchell Mentor-on-the-Map Award from NOBCChE 2023 – Silvia Ronco Innovative Mentor Award from CUR Chemistry 2022 – Henry C. McBay Outstanding Teaching Award from NOBCChE 2021 – Outstanding Mentor of the year Award CUR Health Sciences (Early Career Stage) 2021 – Accessibility and Inclusivity Advocate of the Year: Campus Life Award (Rhodes College) Dr. Stoddard is renowned for her exceptional mentorship of undergraduate researchers, particularly from underrepresented groups in STEM. She established the STEM Cohort Mentoring program at Rhodes in 2017 to support diverse students pursuing STEM careers. Her lab has produced numerous undergraduate co-authors on peer-reviewed publications across multiple disciplines. She has successfully guided many students into medical schools and graduate programs. Dr. Stoddard has secured competitive funding for her research, including participation in the Project Kaleidoscope STEM Leadership Institute held by the American Association of Colleges & Universities. The Molecular Immunotherapeutics Research (MIR) lab at Rhodes College is a vibrant research environment where undergraduate students work alongside Dr. Stoddard on cutting-edge biomedical research. The lab currently pursues four major research projects: 1) Protein Engineering and Development of Antigen Specific Therapeutics for Autoimmune Disorders; 2) Modeling and Investigation of Structure and Function Relationships of Unsolved Protein Structures; 3) Design, Synthesis, and Biological Testing of Novel Therapeutic Compounds for Cancer, Autoimmune, and Neurological Disorders; and 4) Development of Broad-Spectrum Coronavirus Antivirals. The MIR lab collaborates with researchers at institutions including Boston University Medical College, University of Mississippi, and St. Jude Children's Research Hospital.
Professor David Lynn is a leading academic in Systems Immunology at Flinders University and Scientific Director of the SA Genomics Centre, with affiliations to the South Australian Health and Medical Research Institute (SAHMRI) and College of Medicine and Public Health. He has held these positions since 2020 and 2019, respectively. BA (Trinity College Dublin, Genetics; 2000) MSc (University of Ottawa, Bioinformatics & Bacterial Genomics; 2001) PhD (University College Dublin, Immunology; 2004) His research interests focus on systems immunology, exploring how microbes (pathogenic and commensal) modulate immune responses in contexts such as infection, vaccination, and cancer therapies. He integrates computational modeling, bioinformatics, and preclinical mouse models to advance understanding of trained immunity and vaccine mechanisms. Recent research trends show his work spans vaccine responses, microbiota interactions, and genomics. Notable projects include the Gates Foundation-funded BRACE trial on BCG vaccine effects against COVID-19 and NHMRC-funded studies on microbiota's role in vaccination. His scientific awards include: 2023-2028: BioPlatforms Australia National Research Infrastructure funding 2023-2024: GPN Vaccines Collaborative Research Agreement 2023-2028: South Australian Government NCRIS Co-investment Grant 2023-2026: NHMRC Ideas Grant on gut microbiota and vaccine responses 2023-2025: ARC Discovery Project on androgen receptor and lipid metabolism He supervises research teams and contributes to clinical studies and genomics infrastructure development, with grants exceeding $30 million from NHMRC, GSK, and Cancer Australia. His work aligns with UN SDGs in health and well-being, reduced inequalities, and industry innovation.
Dr. Joyce Gonzales is a Professor in the Department of Medicine (Pulmonary Division) at the Medical College of Georgia. She holds an MD from the University of Health Sciences (2002) and a BSN from Excelsior College (1998), with certifications in ACLS instruction (2007), Georgia state physician licensure (2009), and American Board of Internal Medicine (2006). Her research focuses on pulmonary and vascular pathophysiology, including bacterial toxin mechanisms in lung injury, endothelial barrier regulation in sickle cell disease, and novel anticoagulant therapies. Key areas include: Molecular pathways of pneumolysin-induced endothelial damage Thrombin-PAR signaling in vascular permeability Pulmonary complications of hematological disorders Therapeutic interventions for acute chest syndrome She has received multiple honors for service excellence: William Beaumont Army Medical Center Humanitarian Award (2003) Department of the Army Commander’s Award for Civilian Service (1999) Department of the Army Service Recognition (1996) Larimer County Health Department Service Award (1993) Dr. Gonzales teaches core medical courses including RMED 5000 (Medicine), GMED 5034 (Medical Critical Care), and RPUL 5000 (Pulmonary & Critical Care).
Aurora Martinez is a Professor in the Department of Biomedicine at the University of Bergen, Faculty of Medicine. She leads the Biorecognition research group, focusing on the structural and functional aspects of biomolecules in neurometabolic disorders such as phenylketonuria (PKU) and dopamine synthesis defects. She is also a partner in the KG Jebsen Centre for Neuropsychiatric Disorders and a Toppforsk-funded project on the Arc protein, a master regulator of synaptic plasticity. Position: Professor Institution: University of Bergen Department: Department of Biomedicine Research Group: Biorecognition Email: aurora.martinez@uib.no Her research integrates structural biology, molecular recognition, and drug discovery to develop therapeutic strategies for genetic and neurodegenerative diseases. Key areas include tyrosine hydroxylase regulation, mitochondrial dysfunction in dopaminergic cells, and neurotransmitter transport mechanisms. She employs biochemical, cellular, and computational approaches to understand disease mechanisms and identify novel therapeutics. The recent publications (2023–2025) reflect a strong trend toward understanding dopamine-related pathways, protein stabilization, and therapeutic interventions in Parkinsonism and related disorders. Themes include chaperone-mediated protein stabilization, high-throughput screening for VMAT2 modulators, and computational tools for drug discovery. The work combines experimental validation with translational applications in neurodegenerative models. She has supervised multiple Master’s students, including Md. Ekhtear Mahmud, Sofie Breisnes Wormdahl, and Kristine Kippersund Brokstad, indicating active mentorship and training roles. Her involvement in large-scale collaborative projects highlights leadership and interdisciplinary engagement. While no specific awards are listed, her participation in prestigious programs like Toppforsk and the KG Jebsen Centre underscores recognition and funding success. She has no listed grants explicitly, but project affiliations suggest competitive funding support. Her research group maintains strong technical capabilities in protein analysis, cellular screening, and structural modeling. The Martinez Lab is actively involved in both fundamental and applied research, with future directions likely to expand into gene therapy, precision medicine for metabolic disorders, and neuroprotective strategies.
Ali Ertürk is a Professor at Helmholtz Zentrum München, serving as Director of the Institute for Tissue Engineering and Regenerative Medicine (iTERM). His work bridges cutting-edge technology and biomedical innovation, focusing on tissue clearing, spatial-omics, and AI-driven analysis to map biological systems at unprecedented resolution. His research spans three primary areas: Cellular & Systems Neuroscience Theoretical Neuroscience & Technical Applications Biomedical Neuroscience Keywords include tissue clearing, organoids, and neurodegeneration. Selected publications highlight advancements in vDISCO imaging, SHANEL protocols, and AI applications for cancer and neurodegenerative diseases. Graduated students include Dr. Chenchen Pan and Dr. Ruiyao Cai.
